Drawing for PRODO

USPTO serial 87314626

PRODO

Reviewed by CopyMark Law Group

Reg. 5270734Status 702Renewal
Filing date
Status date
Registration date
Aug 22, 2017
Examiner
BRACEY, KAREN
Law office
TMO LAW OFFICE 116

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PRODO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brad A. Hakala

Brad A. Hakala THE HAKALA LAW GROUP, P.C.One World Trade CenterSuite 1870LONG BEACH, CA 90831

Goods and services

ClassDescriptionStatusFirst use
001Cell culture media for scientific and research useACTIVESep 8, 2006
042Laboratory analysis in the field of diabetes; Laboratory research in the field of diabetes; Research and development in the field of diabetes; Research and development of new products; Research in the field of diabetes; Research in the field of products and items to assist others in development treatments for diabetes; Biological research; Biomedical research services; Biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Laboratory research in the field of diabetes; Medical laboratories; Medical laboratory services; Medical research; Medical and scientific research in the field of diabetes; Product research and development; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research consulting in the field of diabetes; Scientific research in the field of diabetesACTIVESep 8, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 22, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 25, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 25, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 25, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 13, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Aug 22, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 22, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 6, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2017DOCKASSIGNED TO EXAMINER—
Jan 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance